Qin Xu

1.6k total citations
57 papers, 1.1k citations indexed

About

Qin Xu is a scholar working on Molecular Biology, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Qin Xu has authored 57 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 18 papers in Oncology and 18 papers in Obstetrics and Gynecology. Recurrent topics in Qin Xu's work include Uterine Myomas and Treatments (11 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Endometriosis Research and Treatment (9 papers). Qin Xu is often cited by papers focused on Uterine Myomas and Treatments (11 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Endometriosis Research and Treatment (9 papers). Qin Xu collaborates with scholars based in China, Japan and United States. Qin Xu's co-authors include Takeshi Maruo, Noriyuki Ohara, Shigeki Yoshida, Richard D. Veenstra, Jiayin Wang, Régine Sitruk‐Ware, Hiroko Sasaki, Koji Nakabayashi, Akira Morikawa and Deborah A. DeManno and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Qin Xu

50 papers receiving 1.1k citations

Peers

Qin Xu
Tzyvia Rye United Kingdom
Kazuo Asanoma Japan
Mark E. Borowsky United States
Adrian A. Suarez United States
Quancai Cui China
Diana R. Licence United Kingdom
Anna F. Lee Canada
Bruce R. Krawisz United States
Kati Kämpjärvi Finland
Tomokazu Umezu Japan
Tzyvia Rye United Kingdom
Qin Xu
Citations per year, relative to Qin Xu Qin Xu (= 1×) peers Tzyvia Rye

Countries citing papers authored by Qin Xu

Since Specialization
Citations

This map shows the geographic impact of Qin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qin Xu more than expected).

Fields of papers citing papers by Qin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qin Xu. The network helps show where Qin Xu may publish in the future.

Co-authorship network of co-authors of Qin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Qin Xu. A scholar is included among the top collaborators of Qin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qin Xu. Qin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jing, et al.. (2025). Efficacy and safety of immunotherapy in cervical cancer: a review of advances in immune-related therapy for cervical cancer. SHILAP Revista de lepidopterología. 4(1). 3 indexed citations
2.
Wang, Yuqin, Xuemei Zhang, Jing Liu, et al.. (2025). Long-Term Outcomes of Local Tumor Destruction/Excision Versus Total Hysterectomy for Stage IA Cervical cancer: A Retrospective Study Based on the SEER Database. International Journal of Women s Health. Volume 17. 711–725.
3.
Chen, Qin, et al.. (2024). The Association Between D-Dimer Levels and Recurrence in Patients with Early-Stage Cervical Cancer after Surgical Treatment. International Journal of Women s Health. Volume 16. 2333–2342. 1 indexed citations
4.
Liu, Long, et al.. (2024). Prediction of cervical lymph node metastasis in solitary papillary thyroid carcinoma based on ultrasound radiomics analysis. Frontiers in Oncology. 14. 1291767–1291767. 2 indexed citations
5.
Zhou, Qi, Gang Chen, Yuanming Shen, et al.. (2023). Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103). Journal of Gynecologic Oncology. 34(3). e55–e55. 3 indexed citations
6.
Xu, Qin, Junjie Wang, Yang Sun, et al.. (2022). Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1–Positive Recurrent or Metastatic Cervical Cancer: A Multicenter, Single-Arm, Prospective Phase II Trial. Journal of Clinical Oncology. 40(16). 1795–1805. 99 indexed citations
7.
Xu, Qin, Zhiyu Huang, Yingying Lin, et al.. (2021). 774P Anlotinib plus sintilimab in patients with recurrent advanced cervical cancer: A prospective, multicenter, single-arm, phase II clinical trial. Annals of Oncology. 32. S752–S753. 1 indexed citations
8.
9.
Patel, Dakshesh, et al.. (2018). Differences in Functional Expression of Connexin43 and NaV1.5 by Pan- and Class-Selective Histone Deacetylase Inhibition in Heart. International Journal of Molecular Sciences. 19(8). 2288–2288. 4 indexed citations
10.
Lin, Wansong, Mei Feng, Xiuhua Li, et al.. (2017). Transcriptome profiling of cancer and normal tissues from cervical squamous cancer patients by deep sequencing. Molecular Medicine Reports. 16(2). 2075–2088. 16 indexed citations
11.
Xu, Qin, Mingang Ying, Guilin Chen, et al.. (2014). ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma. Tumor Biology. 35(8). 7575–7586. 23 indexed citations
12.
Wang, Dan, et al.. (2013). A novel chimeric peptide binds MC3T3-E1 cells to titanium and enhances their proliferation and differentiation. Molecular Medicine Reports. 7(5). 1437–1441. 6 indexed citations
13.
Maruo, Takeshi, Noriyuki Ohara, Shigeki Yoshida, et al.. (2011). Lessons learned from the preclinical drug discovery of asoprisnil and ulipristal for non-surgical treatment of uterine leiomyomas. Expert Opinion on Drug Discovery. 6(9). 897–911. 9 indexed citations
14.
Maruo, Takeshi, Noriyuki Ohara, Shigeki Yoshida, et al.. (2010). Translational research with progesterone receptor modulator motivated by the use of levonorgestrel-releasing intrauterine system. Contraception. 82(5). 435–441. 23 indexed citations
15.
16.
Liu, Ju, Hidetoshi Matsuo, Jovelle B. Laoag‐Fernandez, Qin Xu, & Takeshi Maruo. (2007). The effects of progesterone on apoptosis in the human trophoblast-derived HTR-8/SV neo cells. Molecular Human Reproduction. 13(12). 869–874. 18 indexed citations
17.
Xu, Qin, Noriyuki Ohara, Jin Liu, et al.. (2007). Selective progesterone receptor modulator asoprisnil induces endoplasmic reticulum stress in cultured human uterine leiomyoma cells. American Journal of Physiology-Endocrinology and Metabolism. 293(4). E1002–E1011. 24 indexed citations
18.
Liu, Jin, Hiroya Matsuo, Qin Xu, et al.. (2007). Concentration-dependent effects of a selective estrogen receptor modulator raloxifene on proliferation and apoptosis in human uterine leiomyoma cells cultured in vitro. Human Reproduction. 22(5). 1253–1259. 25 indexed citations
19.
Chen, Wei, Noriyuki Ohara, Jiayin Wang, et al.. (2006). A Novel Selective Progesterone Receptor Modulator Asoprisnil (J867) Inhibits Proliferation and Induces Apoptosis in Cultured Human Uterine Leiomyoma Cells in the Absence of Comparable Effects on Myometrial Cells. The Journal of Clinical Endocrinology & Metabolism. 91(4). 1296–1304. 79 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tzyvia Rye Breakdown of academic impact, for papers by Kazuo Asanoma Breakdown of academic impact, for papers by Mark E. Borowsky Breakdown of academic impact, for papers by Adrian A. Suarez Breakdown of academic impact, for papers by Quancai Cui Breakdown of academic impact, for papers by Diana R. Licence Breakdown of academic impact, for papers by Anna F. Lee Breakdown of academic impact, for papers by Bruce R. Krawisz Breakdown of academic impact, for papers by Kati Kämpjärvi Breakdown of academic impact, for papers by Tomokazu Umezu
Rankless by CCL
2026